VALIDUS PHARMS FDA Approval NDA 021710

NDA 021710

VALIDUS PHARMS

FDA Drug Application

Application #021710

Documents

Letter2009-05-04
Letter2012-11-14
Label2010-10-28
Label2012-11-15
Review2006-07-05
Letter2004-12-10
Letter2006-12-28
Letter2008-01-09
Letter2010-10-27
Letter2012-01-31
Label2004-12-10
Label2006-12-14
Label2009-05-13
Letter2016-09-26
Letter2016-09-26
Label2016-09-29
Label2016-09-29
Medication Guide2018-11-08
Letter2022-10-17
Label2022-10-17
Medication Guide2022-10-17

Application Sponsors

NDA 021710VALIDUS PHARMS

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001CAPSULE, EXTENDED RELEASE;ORAL100MG1EQUETROCARBAMAZEPINE
002CAPSULE, EXTENDED RELEASE;ORAL200MG1EQUETROCARBAMAZEPINE
003CAPSULE, EXTENDED RELEASE;ORAL300MG1EQUETROCARBAMAZEPINE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP2004-12-10STANDARD
LABELING; LabelingSUPPL3AP2006-12-09STANDARD
LABELING; LabelingSUPPL5AP2007-12-19STANDARD
LABELING; LabelingSUPPL6AP2009-04-23901 REQUIRED
LABELING; LabelingSUPPL8AP2010-10-24STANDARD
LABELING; LabelingSUPPL9AP2012-11-13STANDARD
EFFICACY; EfficacySUPPL11AP2016-09-23STANDARD
EFFICACY; EfficacySUPPL12AP2016-09-23STANDARD
REMS; REMSSUPPL13AP2012-01-27N/A
LABELING; LabelingSUPPL18AP2022-10-14STANDARD

Submissions Property Types

ORIG1Null31
SUPPL8Null6
SUPPL9Null6
SUPPL11Null7
SUPPL12Null7
SUPPL13Null7
SUPPL18Null7

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21710
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.